These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3557723)

  • 21. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.
    You J; Cui FD; Han X; Wang YS; Yang L; Yu YW; Li QP
    Colloids Surf B Biointerfaces; 2006 Mar; 48(1):35-41. PubMed ID: 16480856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of multiple dosage bioavailability between phenylpropanolamine controlled release suspension and conventional tablet in healthy volunteers].
    Shen YX; Xu CD; Gao XH; Lin DC; Liu GL
    Yao Xue Xue Bao; 1995; 30(2):157-60. PubMed ID: 7785434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative bioavailability of 2 oral theophylline sustained-release preparations].
    Tritthart W; Lücker PW; Fáy E; Buchebner J
    Arzneimittelforschung; 1983; 33(11):1603-6. PubMed ID: 6686457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation.
    Nosaka H; Takagi K; Hasegawa T; Ogura Y; Mizukami Y; Satake T
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):528-35. PubMed ID: 3781672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability of amfepramone hydrochloride sustained release pellets formulation in healthy subjects.
    Dangor CM; Beckett AH; Veltman AM
    Arzneimittelforschung; 1987 Jun; 37(6):736-9. PubMed ID: 3663274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of bioavailability of experimental controlled release microcapsules of nifedipine.
    Mallick S; Gupta BK; Ghosal SK
    Acta Pol Pharm; 2000; 57(3):175-80. PubMed ID: 11143705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of food on bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms: Part I.
    Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):148-52. PubMed ID: 3699941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bioavailability of theophylline after oral administration of a retard preparation of theophylline-ethylenediamine and the influence of 15-day ingestion on elimination kinetics after i.v. injection (author's transl)].
    Wiessmann KJ
    Arzneimittelforschung; 1980; 30(2):329-32. PubMed ID: 7378114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies of biological availability. A critical assessment based on a study of spironolactone preparations].
    Rameis H; Bacher S
    Wien Med Wochenschr; 1988 Apr; 138(6-7):156-60. PubMed ID: 3394332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of phenylpropanolamine in serum and urine by high-performance liquid chromatography.
    Dowse R; Haigh JM; Kanfer I
    J Pharm Sci; 1983 Sep; 72(9):1018-20. PubMed ID: 6631684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenylpropanolamine pharmacokinetics in dogs after intravenous, oral, and oral controlled-release doses.
    Hussain MA; Aungst BJ; Lam G; Shefter E
    Biopharm Drug Dispos; 1987; 8(5):497-505. PubMed ID: 3663885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained-release drug delivery system I: Coated ion-exchange resin system for phenylpropanolamine and other drugs.
    Raghunathan Y; Amsel L; Hinsvark O; Bryant W
    J Pharm Sci; 1981 Apr; 70(4):379-84. PubMed ID: 7229946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hollow fibers as an oral sustained-release delivery system.
    Hussain MA; DiLuccio RC; Shefter E
    Pharm Res; 1989 Jan; 6(1):49-52. PubMed ID: 2717518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The bioavailability of Ce-Ferro forte].
    Heinrich HC; Gabbe EE
    Med Klin; 1979 Aug; 74(32-33):1196-8. PubMed ID: 470799
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of effects of two dosage regimens of phenylpropanolamine on blood pressure and plasma levels in normal subjects under steady-state conditions.
    Saltzman MB; Dolan MM; Doyne N
    Drug Intell Clin Pharm; 1983 Oct; 17(10):746-50. PubMed ID: 6628229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bioavailability of two quinidin drug-released products (author's transl)].
    Sado PA; Le Verge R; Devissaguet JP
    Therapie; 1979; 34(6):713-26. PubMed ID: 547445
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug adsorption efficacy of commercial activated charcoal tablets in vitro and in man.
    Tsuchiya T; Levy G
    J Pharm Sci; 1972 Apr; 61(4):624-5. PubMed ID: 4552282
    [No Abstract]   [Full Text] [Related]  

  • 38. Bioavailability in man of phendimetrazine from various dosage forms [proceedings].
    Beckett AH; Raisi A
    J Pharm Pharmacol; 1976 Dec; 28 Suppl():40P. PubMed ID: 12316
    [No Abstract]   [Full Text] [Related]  

  • 39. Convulsive seizures due to phenylpropanolamine.
    Deocampo PD
    J Med Soc N J; 1979 Aug; 76(9):591-2. PubMed ID: 295377
    [No Abstract]   [Full Text] [Related]  

  • 40. Administration of drugs 1: Oral route.
    Shepherd M
    Nurs Times; 2011 Aug 16-29; 107(32-33):18. PubMed ID: 21910309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.